Angioplasty, Peripheral Arterial Disease
Conditions
Brief summary
Peripheral arterial disease (PAD) caused by atherosclerosis causes damage to the arteries originating in the aorta (descending) from the iliacs to the extremities of the lower limbs. It causes significant morbidity and mortality. Percutaneous revascularization plays a key role in the management of these patients. Many percutaneous treatment options have been developed: arteriectomy, naked stents, active balloons and active stents. Of these, only paclitaxel-active stents were successful in reducing the rates of restenosis and reoperation in patients with superficial femoral artery injury.The main objective is to study symptomatic improvement at 1 year of patients treated with revascularization of the lower limbs.
Interventions
OTHEROne or two phone call
Phone call to collect patient data
Sponsors
European Clinical Trial Experts Network
Ramsay Générale de Santé
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient treated by the peripheral angioplasty department of Claude Galien Hospital from January 2010 and with at least 1 year of follow-up after the revascularization procedure * Patient treated for symptomatic chronic ischemia of the lower limbs defined by Rutherford categories 2-4 and / or Leriche stage greater than 2a * Stenosis or restenosis (history of balloon angioplasty, active balloon or bare stent) * Degree of stenosis ≥ 50% by angiographic evaluation visual, by CT scan or by Doppler ultrasound * Patient affiliated or beneficiary of a social security scheme * Patient aged 18 or over * Patient having been informed and not opposing this research
Exclusion criteria
* Medical history of myocardial infarction or stroke within 3 months of the revascularization procedure * Unstable angina at the time of the revascularization procedure * Sepsis at the time of the revascularization procedure * Major under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision * Hospitalized without consent * Pregnant, breastfeeding or parturient woman
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Symptomatic improvement will be assessed by the evolution of the Leriche and Rutherford classifications before the revascularization procedure and 1 year after the revascularization procedure | 1 year | Lerich classification : stage I to IV Rutherford : stage 0 to 6 |
Countries
France
Contacts
Primary ContactJean-François Oudet
Backup ContactMarie-Hélène Barba
Outcome results
None listed